
|Videos|January 2, 2018
Updates in Germline Clinical Testing for Breast Cancer
Author(s)Julie Nangia, MD
This video reviews studies investigating the use of germline clinical testing for breast cancer.
Advertisement
In this video, Julie Nangia, MD, of Baylor College of Medicine in Houston, highlights abstracts investigating the use of germline clinical testing for breast cancer, including a study on general population testing and more.
Nangia was a discussant for a spotlight session on this topic at the 2017 San Antonio Breast Cancer Symposium (SABCS), held December 5–9 in San Antonio, Texas.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Lifts Partial Clinical Hold on Lorigerlimab for Gynecologic Cancer
2
FDA Clears At-Home HPV Self-Collection Kit to Expand Cervical Cancer Screening Access
3
Targeting the Tumor Ecosystem to Create Pan–Solid Tumor Vulnerability
4
FDA Issues Second CRL for RP1/Nivolumab in Advanced Melanoma
5





















































